CDA and familial pancreatic carcinoma: And indeed, we have recently shown that treatment with nab-paclitaxel increases intratumoural gemcitabine levels by reducing the levels of Cda protein in cancer cells through induction of reactive oxygen species-mediated degradation.18 This mechanism may partly explain the synergistic effect of this combination treatment in patients with pancreatic cancer.5